✦ LIBER ✦

The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

✍ Scribed by Therasse, P.; Mauriac, L.; Welnicka, M.; Bruning, P.; Cufer, T.; Lichinitser, R.; Pluzanska, A.; Tomiak, E.; Koopmanschap, M.; Piccart, M.

Book ID: 122355841
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 132 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81671-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final Results of a Randomized Phase III

Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study

✍ Therasse, P. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 107 KB

The prognostic value of health-related q

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study

✍ Mauer, M; Stupp, R; Taphoorn, M J B; Coens, C; Osoba, D; Marosi, C; Wong, R; de 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

A study of molecular markers with potent

A study of molecular markers with potential prognostic and predictive value (c-erb b-2, p53, cyclin D1, MIB1, ER and PgR) in locally advanced breast cancer treated with neo-adjuvant dose intensive chemotherapy in an EORTC-NCIC-SAKK randomized phase III study

✍ H. Bonnefoi; S. Diebold-Berger; A. Hamilton; M. van de Vijver; G. Mac Grogan; L. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 158 KB

115 - Immediate hormonotherapy with an L

115 - Immediate hormonotherapy with an LHRH analogue improves local control and survival in patients with locally advanced prostate cancer treated by radiotherapy. A randomized phase III clinical trial of the EORTC

✍ M. Bolla; D. Gonzalez; P. Warde; J.B. Dubois; R. Mirimanoff; G. Storme; J. Berni 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 242 KB

A randomized phase III clinical trial of

A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life

✍ Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Carlo Floris; El 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 553 KB

127Immediate hormonal therapy improves l

127Immediate hormonal therapy improves locoregional control and survival in patients with locally advanced prostate cancer. Results of a randomized phase III clinical trial of the eortc radiotherapy and genito-urinary tract cancer cooperative groups

✍ Bolla, M.; Gonzelez, D.; Warde, P.; Dubois, J.B.; Mirimanoff, R.; Storme, G.; Be 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 105 KB